These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 3168904)
1. [The central effects of 2 groups of newly synthesized barbiturates]. Getova D Eksp Med Morfol; 1988; 27(2):17-24. PubMed ID: 3168904 [No Abstract] [Full Text] [Related]
2. [To the study of the mechanism of potentiation of hypnotic effect of hexenal by 3,5-dimethyl-4-brompyrazol]. Avakumov VM; Batulin IuM Farmakol Toksikol; 1968; 31(4):402-5. PubMed ID: 5698126 [No Abstract] [Full Text] [Related]
3. General pharmacological actions of some synthetic tetrahydrocannabinol derivatives. Hardman HF; Domino EF; Seevers MH Pharmacol Rev; 1971 Dec; 23(4):295-315. PubMed ID: 5002533 [No Abstract] [Full Text] [Related]
4. Pharmacological properties of substituted gamma-butyrolactones. I. The effects on the central nervous system. Sieroslawska J; Hano J; Sypniewska M; Czarnecki R; Chojnacka-Wójcik E; Harasiewicz A Pol J Pharmacol Pharm; 1973; 25(1):1-16. PubMed ID: 4798097 [No Abstract] [Full Text] [Related]
5. Stereostructure-activity relationships for oxazepam hemisuccinate. Effects on central nervous system. de Angelis L; Predominato M; Vertua R Arzneimittelforschung; 1972 Aug; 22(8):1328-33. PubMed ID: 4678394 [No Abstract] [Full Text] [Related]
6. Interactions of delta-tetrahydrocannabinol with barbiturates and methamphetamine. Kubena RK; Barry H J Pharmacol Exp Ther; 1970 May; 173(1):94-100. PubMed ID: 5442307 [No Abstract] [Full Text] [Related]
7. Influence of new monoterpene homologues of GABA on the central nervous system activity in mice. Librowski T; Czarnecki R; Mendyk A; Jastrzebska M Pol J Pharmacol; 2000; 52(4):317-21. PubMed ID: 11345489 [TBL] [Abstract][Full Text] [Related]
8. Studies on some aspects of the neuropharmacology of butylurea. Dar MS; Fakouhi T Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):204-12. PubMed ID: 4854473 [No Abstract] [Full Text] [Related]
9. [Demonstration of a depressive component in the central effects of nikethamide]. Buchel L; Absil J Arch Sci Physiol (Paris); 1972; 26(2):175-94. PubMed ID: 4265482 [No Abstract] [Full Text] [Related]
10. Pharmacological and behavioral effects of mono- and disubstituted chlorpromazine derivatives. Buckley JP; Steenberg ML; Barry H; Manian AA Adv Biochem Psychopharmacol; 1974; 9(0):617-31. PubMed ID: 4836226 [No Abstract] [Full Text] [Related]
12. New derivatives of alpha-ethyl-alpha-allophanyl-gamma-valerolactone. Bobrański B; Sedzimirska B; Barczyńska J; Kedzierska L Arch Immunol Ther Exp (Warsz); 1970; 18(5):584-90. PubMed ID: 5493485 [No Abstract] [Full Text] [Related]
13. The interaction of barbital and testosterone relative to their hypnotic effects. Gessner PK; Gessner T Arch Int Pharmacodyn Ther; 1973 Jan; 201(1):52-8. PubMed ID: 4717387 [No Abstract] [Full Text] [Related]
15. Pharmacologic properties of the dilactone of bis-(beta-hydroxypropyl)-malonic acid. Pelczarska A; Prastowski W Arch Immunol Ther Exp (Warsz); 1967; 15(6):912-9. PubMed ID: 5586112 [No Abstract] [Full Text] [Related]
16. Synthesis and pharmacological evaluation of some 2-N-alkyl-and -aralkyl-3,4:6,7-dibenzomorphans. Sharma R; Joshi BC; Dua PR Pharmazie; 1980; 35(9):542-3. PubMed ID: 7433504 [TBL] [Abstract][Full Text] [Related]
17. Interactions of chronic and acute 1 -tetrahydrocannabinol pretreatment with zoxazolamine and barbiturates. Sofia RD Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):91-8. PubMed ID: 4686112 [No Abstract] [Full Text] [Related]
18. [Effect of alaphen on some functions of central nervous system]. Masiuta GF Farmakol Toksikol; 1966; 29(5):524-7. PubMed ID: 5995061 [No Abstract] [Full Text] [Related]
19. [Optically active barbiturates. Synthesis, configuration and pharmacological effects (author's transl)]. Knabe J; Rummel W; Büch HP; Franz N Arzneimittelforschung; 1978; 28(7):1048-56. PubMed ID: 385006 [TBL] [Abstract][Full Text] [Related]
20. Potencies of barbiturates in mice selectively bred for resistance or susceptibility to nitrous oxide anesthesia. Koblin DD; Lurz FW; O'Connor B; Nelson NT; Eger EI; Bainton CR Anesth Analg; 1984 Jan; 63(1):35-9. PubMed ID: 6691562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]